LFVN Stock - LifeVantage Corporation
Unlock GoAI Insights for LFVN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $228.53M | $200.16M | $213.40M | $206.36M | $220.18M |
| Gross Profit | $183.67M | $158.72M | $170.01M | $168.26M | $181.99M |
| Gross Margin | 80.4% | 79.3% | 79.7% | 81.5% | 82.7% |
| Operating Income | $12.20M | $4.33M | $4.26M | $7.58M | $17.61M |
| Net Income | $9.80M | $2.94M | $2.54M | $3.12M | $12.89M |
| Net Margin | 4.3% | 1.5% | 1.2% | 1.5% | 5.9% |
| EPS | $0.80 | $0.24 | $0.20 | $0.24 | $0.92 |
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| January 14th 2025 | Craig Hallum | Initiation | Buy | $35 |
| December 19th 2024 | Lake Street | Initiation | Buy | $26 |
Earnings History & Surprises
LFVNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $0.22 | — | — | — |
Q4 2025 | Nov 4, 2025 | $0.17 | $0.18 | +5.9% | ✓ BEAT |
Q3 2025 | Sep 4, 2025 | $0.17 | $0.17 | 0.0% | = MET |
Q2 2025 | May 6, 2025 | $0.16 | $0.26 | +62.5% | ✓ BEAT |
Q1 2025 | Feb 5, 2025 | $0.13 | $0.22 | +69.2% | ✓ BEAT |
Q4 2024 | Oct 29, 2024 | $0.15 | $0.15 | 0.0% | = MET |
Q3 2024 | Aug 28, 2024 | $0.21 | $0.14 | -33.3% | ✗ MISS |
Q2 2024 | May 2, 2024 | $0.16 | $0.21 | +31.2% | ✓ BEAT |
Q1 2024 | Jan 30, 2024 | $0.04 | $0.10 | +150.0% | ✓ BEAT |
Q4 2023 | Nov 9, 2023 | — | $0.13 | — | — |
Q3 2023 | Aug 28, 2023 | $0.20 | $0.17 | -15.0% | ✗ MISS |
Q2 2023 | May 4, 2023 | $0.15 | $0.08 | -46.7% | ✗ MISS |
Q1 2023 | Feb 2, 2023 | $0.05 | $-0.07 | -240.0% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $0.15 | $0.06 | -60.0% | ✗ MISS |
Q3 2022 | Aug 23, 2022 | $0.14 | $0.01 | -92.9% | ✗ MISS |
Q2 2022 | May 3, 2022 | $0.11 | $0.12 | +9.1% | ✓ BEAT |
Q1 2022 | Feb 1, 2022 | $0.24 | $0.05 | -79.2% | ✗ MISS |
Q4 2021 | Nov 4, 2021 | $0.21 | $0.23 | +9.5% | ✓ BEAT |
Q3 2021 | Aug 19, 2021 | $0.20 | $0.31 | +55.0% | ✓ BEAT |
Latest News
LifeVantage Trial Results From New In Vitro Demonstrates All 14 Peptides Influences In Desired Direction
📈 PositiveLifevantage Corporation shares are trading higher. The company reported Q1 financial results.
📈 PositiveLifevantage Affirms FY2026 Adj EPS Guidance of $1.00-$1.15 vs $0.97 Est; Affirms FY2026 Sales Guidance of $225.000M-$240.000M vs $239.567M Est
📈 PositiveLifevantage Q1 Adj. EPS $0.18, Inline, Sales $47.561M Miss $54.750M Estimate
📉 NegativeCORRECTION: On September 4, 2025 Lifevantage Reported That It Sees FY2026 Adj EPS $1.00-$1.15 vs $1.00 Est; Sees Sales $225.000M-$240.000M vs $252.400M Est
📉 NegativeLifevantage shares are trading lower after the company reported worse-than-expected Q4 sales results.
📉 NegativeLifeVantage Posts 13% Revenue Gain in Q4
📈 PositiveLifeVantage falls after earnings miss, LoveBiome revenue outlook unclear
📉 NegativeLifevantage Sees FY2026 Adj EPS $1.00-$1.15 vs $0.80 Est; Sees Sales $225.000M-$240.000M vs $230.300M Est
📈 PositiveLifevantage Q4 Adj. EPS $0.17 Beats $0.15 Estimate, Sales $55.114M Miss $56.900M Estimate
➖ NeutralLifeVantage Acquires LoveBiome; Terms Not Disclosed
➖ NeutralFrequently Asked Questions about LFVN
What is LFVN's current stock price?
What is the analyst price target for LFVN?
What sector is LifeVantage Corporation in?
What is LFVN's market cap?
Does LFVN pay dividends?
Similar Stocks
Consumer Defensive SectorExplore stocks similar to LFVN for comparison